Surface display of the 20-kDa N-terminal fragment of anthrax protective antigen based on attenuated recombinant Bacillus anthracis

World Journal of Microbiology and Biotechnology

Volumn 27, Issue 11, 2011, Pages 2575-2581

  Wang, Yan chun ^a   Jiang, Na ^a,b   Zhan, De wen ^a   Tao, Hao xia ^a   Yuan, Sheng ling ^a   Wang, Peng ^a   Wang, Ling chun ^a   Zhang, Zhao shan ^a   Liu, Chun jie ^a  

^a BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

^b Beijing Fisheries Research Institute   (China)

Author keywords

Bacillus anthracis; Cre loxP system; Surface display; Vaccine vehicle

Indexed keywords

ANTHRACIS; ANTHRAX VACCINES; BACILLUS ANTHRACIS; CRE RECOMBINASE; CRE-LOXP; DNA FRAGMENT; EXPERIMENT METHODS; EXTRACELLULAR; FUSION PARTNERS; GUINEA PIGS; IMMUNOFLUORESCENCE ANALYSIS; N-TERMINALS; POTENTIAL APPLICATIONS; PROTECTIVE ANTIGENS; RECOMBINANT BACILLI; S-LAYER PROTEINS; S-LAYERS; SODIUM DODECYL SULFATE-POLYACRYLAMIDE GEL ELECTROPHORESIS; SPECTINOMYCIN; SURFACE DISPLAY; SURFACE DISPLAYS; SURFACE LAYERS; THERMO SENSITIVE; TRANSLATIONAL FUSION; WESTERN-BLOT ANALYSIS;

ANTIBIOTICS; BACILLI; BACTERIOLOGY; ELECTROPHORESIS; SODIUM; SODIUM SULFATE;

ANTIGENS;

BACILLI (CLASS); BACILLUS ANTHRACIS; CAVIA;

EID: 80053337282     PISSN: 09593993     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11274-011-0729-z     Document Type: Article

References (17)

1. Aloni-Grinstein R, Gat O, Altboum Z, Velan B, Cohen S, Shafferma A (2005) Oral spore vaccine based on live attenuated nontoxinogenic B. anthracis expressing recombinant mutant protective antigen. Infect Immun 73: 4043-4053. doi: 10. 1128/IAI. 73. 7. 4043-4053. 2005.
2. Arnaud M, Chastanet A, De′barbouille M (2004) New vector for efficient allelic replacement in naturally nontransformable, low-GC-content, gram-positive bacteria. Appl Environ Microb 70: 6887-6891. doi: 10. 1128/AEM. 70. 11. 6887-6891. 2004.
3. Duc le H, Cutting SM (2003) Bacterial spores as heat stable vaccine vehicles. Expert Opin Biol Ther 3: 1263-1270. doi: 10. 1517/14712598. 3. 8. 1263.
4. Duc le H, Hong HA, Fairweather N, Ricca E, Cutting SM (2003) Bacterial spores as vaccine vehicles. Infect Immun 71: 2810-2818. doi: 10. 1128/IAI. 71. 5. 2810-2818. 2003.
5. Hoa TT, Duc LH, Isticato R, Baccigalupi L, Ricca E, van PH, Cutting SM (2001) Fate and dissemination of B. subtilis spores in a murine model. Appl Environ Microbiol 67: 3819-3823. doi: 10. 1128/AEM. 67. 9. 3819-3823. 2001.
6. Kaur M, Chug H, Singh H, Chandra S, Mishra M, Sharma M, Bhatnagar R (2009) Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of B. anthracis. Mol Immun 46: 2107-2115. doi: 10. 1016/j. molimm. 2008. 12. 031.
7. Mesnage S, Tosi-Couture E, Mock M, Gounon P, Fouet A (1997) Molecular characterization of the B. anthracis main S-layer component: evidence that it is the major cell-associated antigen. Mol Microbiol 23: 1147-1155. doi: 10. 1046/j. 1365-2958. 1997. 2941659. x.
8. Mesnage S, Tosi-Couture E, Mock M, Fouet A (1999a) The S-layer homology domain as a means for anchoring heterologous proteins on the cell surface of B. anthracis. J Appl Microbiol 87: 256-260. doi: 10. 1046/j. 1365-2672. 1999. 00880. x.
9. Mesnage S, Weber-Levy M, Haustant M, Mock M, Fouet A (1999b) Cell surface-exposed tetanus toxin fragment C produced by recombinant B. anthracis protects against tetanus toxin. Infect Immun 67: 4847-4850.
10. Mesnage S, Tosi-Couture E, Fouet A (1999c) Production and cell surface anchoring of functional fusions between the SLH motifs of the B. anthracis S-layer proteins and the B. subtilis levansucrase. Mol Microbiol 31: 927-936. doi: 10. 1046/j. 1365-2958. 1999. 01232. x.
11. Mohamadzadeh M (2010) Induction of protective immunity against microbial challenge by targeting antigens expressed by probiotic bacteria to mucosal dendritic cells. Curr HIV Res 8: 323-329.
12. Pomerantsev AP, Sitaraman R, Galloway CR, Kivovich V, Leppla SH (2006) Genome Engineering in B. anthracis using Cre recombinase. Infect Immun 74: 682-693. doi: 10. 1128/IAI. 74. 1. 682-693. 2006.
13. Reason D, Ullal A, Liberato J, Sun JY, Keitel W, Zhou JH (2008) Domain specificity of the human antibody response to B. anthracis protective antigen. Vaccine 26: 4041-4047. doi: 10. 1016/j. vaccine. 2008. 05. 023.
14. Shatalin KY, Neyfakh AA (2005) Efficient gene inactivation in B. anthracis. FEMS Microbiol Lett 245: 315-319. doi: 10. 1016/j. femsle. 2005. 03. 029.
15. Sleytr UB, Beveridge TJ (1999) Bacterial S-layers. Trends Microbiol 7: 253-260. doi: 10. 1016/S0966-842X(99)01513-9.
16. Tournier JN, amd Mohamadzadeh M (2010) Key roles of dendritic cells in lung infection and improving anthrax vaccines. Trends Mol Med 16: 303-312. doi: 10. 1016/j. molmed. 2010. 04. 006.
17. Wang YC, Jiang N, Zhan DW, Qiu Y, Yuan SL, Tao HX, Wang LC, Zhang ZS, Liu CJ (2009) Application of cre-LoxP system in the gene knockout of B. anthracis and the knockout of eag gene. Prog Biochem Biophys 36: 934-940. doi: 10. 3724/SP. J. 1206. 2008. 00687.